142 results on '"Guo, Xiling"'
Search Results
2. Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trial
3. Effectiveness of Disinfectants Suitable for Inactivating SARS-CoV-2 at Cold-Chain Temperature
4. Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial
5. Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study
6. In vitro inactivation of SARS-CoV-2 by commonly used disinfection products and methods
7. The 6-Month Antibody Durability of Heterologous Convidecia Plus CoronaVac and Homologous CoronaVac Immunizations in People Aged 18–59 Years and over 60 Years Based on Two Randomized Controlled Trials in China
8. An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
9. Fast and long-lasting immune response to S-trimer COVID-19 vaccine adjuvanted by PIKA
10. Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial
11. Ultrapotent neutralizing antibodies against SARS-CoV-2 with a high degree of mutation resistance
12. Severe human infection with a novel avian-origin influenza A(H7N4) virus
13. Antibody persistence and safety after heterologous boosting with orally aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously: 12-month analyses of a randomized controlled trial.
14. Antibody persistence and safety after heterologous boosting with orally aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously: 12-month analyses of a randomized controlled trial
15. Identification and genetic characterization of a novel circular single-stranded DNA virus in a human upper respiratory tract sample
16. A novel pyrosequencing assay for the detection of neuraminidase inhibitor resistance-conferring mutations among clinical isolates of avian H7N9 influenza virus
17. Antibody Persistence and Safety through 6 Months after Heterologous Orally Aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously
18. Heterologous CoronaVac plus Ad5-nCOV versus homologous CoronaVac vaccination among elderly: a phase 4, non-inferiority, randomized study
19. Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): a randomized, observer-blinded, placebo-controlled trial
20. Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients
21. Heterologous prime-boost immunization with CoronaVac and Convidecia
22. In vitro inactivation of SARS-CoV-2 by commonly used disinfection products and methods
23. Detection of novel SARS-like and other coronaviruses in bats from Kenya
24. Ultrasensitive detection of Shiga toxin 2 and its variants in Shiga toxin-producingEscherichia colistrains by a time-resolved fluorescence immunoassay
25. HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV
26. Development and application of a one-step real-time RT-PCR using a minor-groove-binding probe for the detection of a novel bunyavirus in clinical specimens
27. Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China
28. Neutralizing Antibodies Isolated by a site-directed Screening have Potent Protection on SARS-CoV-2 Infection
29. HTCC as a highly effective polymeric inhibitor of SARS-CoV-2 and MERS-CoV
30. A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
31. Construction of immune human library and screening of neutralizing antibodies specific to glycoprotein of severe fever with thrombocytopenia syndrome virus
32. Altered serum microRNAs as biomarkers for the early diagnosis of pulmonary tuberculosis infection
33. A cluster of cases of severe fever with thrombocytopenia syndrome bunyavirus infection in China, 1996: A retrospective serological study
34. Ultrasensitive detection of Shiga toxin 2 and its variants in Shiga toxin-producingEscherichia colistrains by a time-resolved fluorescence immunoassay
35. Engineering and evaluation of a mouse/human chimeric antibody against Shiga toxin 2
36. High-throughput sequencing of microRNAs in adenovirus type 3 infected human laryngeal epithelial cells
37. First imported case of Zika virus infection into Jiangsu Province, China, returning from Ecuador
38. Increased Prevalence of Severe Fever with Thrombocytopenia Syndrome in Eastern China Clustered with Multiple Genotypes and Reasserted Virus during 2010–2015
39. Simultaneous detection of hemagglutinin and neuraminidase genes of novel influenza A (H7N9) by duplex real-time reverse transcription polymerase chain reaction
40. Ultrasensitive detection of Shiga toxin 2 and its variants in Shiga toxin‐producing Escherichia coli strains by a time‐resolved fluorescence immunoassay.
41. Experimental and Natural Infections of Goats with Severe Fever with Thrombocytopenia Syndrome Virus: Evidence for Ticks as Viral Vector
42. Complete Genome Sequence of a Novel Reassortant Avian Influenza H9N9 Virus Isolated from Chicken in Eastern China
43. Seroprevalence and Risk Factors for Severe Fever with Thrombocytopenia Syndrome Virus Infection in Jiangsu Province, China, 2011
44. Dynamic reassortments and genetic heterogeneity of the human-infecting influenza A (H7N9) virus
45. Human Antibody Neutralizes Severe Fever with Thrombocytopenia Syndrome Virus, an Emerging Hemorrhagic Fever Virus
46. Rapid and Sensitive Detection of Novel Avian-Origin Influenza A (H7N9) Virus by Reverse Transcription Loop-Mediated Isothermal Amplification Combined with a Lateral-Flow Device
47. Development and application of a one‐step real‐time RT‐PCR using a minor‐groove‐binding probe for the detection of a novel bunyavirus in clinical specimens
48. Detection of Severe Fever with Thrombocytopenia Syndrome Virus by Reverse Transcription–Cross-Priming Amplification Coupled with Vertical Flow Visualization
49. A miniature e-learning portal of full teaching and learning capacity
50. Preparation and Evaluation of Recombinant Severe Fever with Thrombocytopenia Syndrome Virus Nucleocapsid Protein for Detection of Total Antibodies in Human and Animal Sera by Double-Antigen Sandwich Enzyme-Linked Immunosorbent Assay
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.